Literature DB >> 21356339

Regulation of gene expression and subcellular protein distribution in MLO-Y4 osteocytic cells by lysophosphatidic acid: Relevance to dendrite outgrowth.

Katrina M Waters1, Jon M Jacobs, Marina A Gritsenko, Norman J Karin.   

Abstract

Osteoblastic and osteocytic cells are highly responsive to the lipid growth factor lysophosphatidic acid (LPA) but the mechanisms by which LPA alters bone cell functions are largely unknown. A major effect of LPA on osteocytic cells is the stimulation of dendrite membrane outgrowth, a process that we predicted to require changes in gene expression and protein distribution. We employed DNA microarrays for global transcriptional profiling of MLO-Y4 osteocytic cells grown for 6 and 24h in the presence or absence of LPA. We identified 932 transcripts that displayed statistically significant changes in abundance of at least 1.25-fold in response to LPA treatment. Gene ontology (GO) analysis revealed that the regulated gene products were linked to diverse cellular processes, including DNA repair, response to unfolded protein, ossification, protein-RNA complex assembly, and amine biosynthesis. Gene products associated with the regulation of actin microfilament dynamics displayed the most robust expression changes, and LPA-induced dendritogenesis in vitro was blocked by the stress fiber inhibitor cytochalasin D. Mass spectrometry-based proteomic analysis of MLO-Y4 cells revealed significant LPA-induced changes in the abundance of 284 proteins at 6h and 844 proteins at 24h. GO analysis of the proteomic data linked the effects of LPA to cell processes that control of protein distribution and membrane outgrowth, including protein localization, protein complex assembly, Golgi vesicle transport, cytoskeleton-dependent transport, and membrane invagination/endocytosis. Dendrites were isolated from LPA-treated MLO-Y4 cells and subjected to proteomic analysis to quantitatively assess the subcellular distribution of proteins. Sets of 129 and 36 proteins were enriched in the dendrite fraction as compared to whole cells after 6h and 24h of LPA exposure, respectively. Protein markers indicated that membranous organelles were largely excluded from the dendrites. Highly represented among the proteins with elevated abundances in dendrites were molecules that regulate cytoskeletal function, cell motility and membrane adhesion. Our combined transcriptomic/proteomic analysis of the response of MLO-Y4 osteocytic cells to LPA indicates that dendritogenesis is a membrane- and cytoskeleton-driven process with actin dynamics playing a particularly critical role.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21356339      PMCID: PMC3095666          DOI: 10.1016/j.bone.2011.02.020

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  56 in total

Review 1.  Data merging for integrated microarray and proteomic analysis.

Authors:  Katrina M Waters; Joel G Pounds; Brian D Thrall
Journal:  Brief Funct Genomic Proteomic       Date:  2006-05-10

2.  Multiple testing. Part I. Single-step procedures for control of general type I error rates.

Authors:  Sandrine Dudoit; Mark J van der Laan; Katherine S Pollard
Journal:  Stat Appl Genet Mol Biol       Date:  2004-06-09

3.  Isolation and characterization of a cDNA clone encoding a novel peptide (OSF) that enhances osteoclast formation and bone resorption.

Authors:  S Reddy; R Devlin; C Menaa; R Nishimura; S J Choi; M Dallas; T Yoneda; G D Roodman
Journal:  J Cell Physiol       Date:  1998-12       Impact factor: 6.384

4.  Evidence for the involvement of two pathways in activation of extracellular signal-regulated kinase (Erk) and cell proliferation by Gi and Gq protein-coupled receptors in osteoblast-like cells.

Authors:  J Caverzasio; G Palmer; A Suzuki; J P Bonjour
Journal:  J Bone Miner Res       Date:  2000-09       Impact factor: 6.741

5.  The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases.

Authors:  Ahmed Boucharaba; Claire-Marie Serre; Julien Guglielmi; Jean-Claude Bordet; Philippe Clézardin; Olivier Peyruchaud
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-12       Impact factor: 11.205

6.  Requirement for the lpA1 lysophosphatidic acid receptor gene in normal suckling behavior.

Authors:  J J Contos; N Fukushima; J A Weiner; D Kaushal; J Chun
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

7.  Effects of sphingosine-1-phosphate and lysophosphatidic acid on human osteoblastic cells.

Authors:  R Dziak; B M Yang; B W Leung; S Li; N Marzec; J Margarone; L Bobek
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2003-03       Impact factor: 4.006

8.  Quantitative proteome analysis of human plasma following in vivo lipopolysaccharide administration using 16O/18O labeling and the accurate mass and time tag approach.

Authors:  Wei-Jun Qian; Matthew E Monroe; Tao Liu; Jon M Jacobs; Gordon A Anderson; Yufeng Shen; Ronald J Moore; David J Anderson; Rui Zhang; Steve E Calvano; Stephen F Lowry; Wenzhong Xiao; Lyle L Moldawer; Ronald W Davis; Ronald G Tompkins; David G Camp; Richard D Smith
Journal:  Mol Cell Proteomics       Date:  2005-03-07       Impact factor: 5.911

9.  Lysophosphatidic acid induces osteocyte dendrite outgrowth.

Authors:  Sue A Karagiosis; Norman J Karin
Journal:  Biochem Biophys Res Commun       Date:  2007-03-28       Impact factor: 3.575

10.  Multiple actions of lysophosphatidic acid on fibroblasts revealed by transcriptional profiling.

Authors:  Catelijne Stortelers; Ron Kerkhoven; Wouter H Moolenaar
Journal:  BMC Genomics       Date:  2008-08-14       Impact factor: 3.969

View more
  6 in total

Review 1.  Lysophosphatidic Acid and Sphingosine-1-Phosphate: A Concise Review of Biological Function and Applications for Tissue Engineering.

Authors:  Bernard Y K Binder; Priscilla A Williams; Eduardo A Silva; J Kent Leach
Journal:  Tissue Eng Part B Rev       Date:  2015-07-14       Impact factor: 6.389

Review 2.  [Research progress on the biological regulatory function of lysophosphatidic acid in bone tissue cells].

Authors:  Xiang-Nan Wu; Yuan-Yuan Ma; Zhi-Chao Hao; Hang Wang
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2020-06-01

Review 3.  Pathways Controlling Formation and Maintenance of the Osteocyte Dendrite Network.

Authors:  Jialiang S Wang; Marc N Wein
Journal:  Curr Osteoporos Rep       Date:  2022-09-10       Impact factor: 5.163

4.  Integrative transcriptomic and proteomic analysis of osteocytic cells exposed to fluid flow reveals novel mechano-sensitive signaling pathways.

Authors:  Peter M Govey; Jon M Jacobs; Susan C Tilton; Alayna E Loiselle; Yue Zhang; Willard M Freeman; Katrina M Waters; Norman J Karin; Henry J Donahue
Journal:  J Biomech       Date:  2014-03-25       Impact factor: 2.712

5.  Absence of the lysophosphatidic acid receptor LPA1 results in abnormal bone development and decreased bone mass.

Authors:  Isabelle Gennero; Sara Laurencin-Dalicieux; Françoise Conte-Auriol; Fabienne Briand-Mésange; Danielle Laurencin; Jackie Rue; Nicolas Beton; Nicole Malet; Marianne Mus; Akira Tokumura; Philippe Bourin; Laurence Vico; Gérard Brunel; Richard O C Oreffo; Jerold Chun; Jean Pierre Salles
Journal:  Bone       Date:  2011-05-01       Impact factor: 4.398

Review 6.  Autotaxin/Lysophosphatidic Acid Axis: From Bone Biology to Bone Disorders.

Authors:  Candide Alioli; Léa Demesmay; Olivier Peyruchaud; Irma Machuca-Gayet
Journal:  Int J Mol Sci       Date:  2022-03-22       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.